Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.Blood|June 20, 2025
Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell LymphomaShinya Rai, Gerben Duns, Fabian Frontzek, et al.Blood Advances|July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMalgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K Hilton, Henry S Ngu, Brett Collinge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNathalie A Johnson, Graham W Slack, Kerry J Savage, et al.Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP studyBrett Collinge, Laura K Hilton, Jasper Wong, et al.Blood|March 2, 2013
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium ProgramShimin Hu, Zijun Y Xu-Monette, Alexander Tzankov, et al.Nature Communications|October 3, 2018
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphomaSarah E Arthur, Aixiang Jiang, Bruno M Grande, et al.Pageof 9